Inclusion Criteria:  >= 18 Years of Age Informed consent is provided Histologically confirmed resectable non-small cell lung cancer with stage II-IIIA (TNM 8th edition) Eastern Cooperative Oncology Group (ECOG) performance status 0-1 Epidermal growth factor receptor (EGFR) mutation negative and anaplastic lymphoma kinase (ALK) translocation negative  Exclusion Criteria:  EGFR mutation positive and ALK translocation positive Active central nervous system (CNS) metastases Autoimmune diseases Inhaled or topical steroids, and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active autoimmune disease Patients with interstitial lung disease will not be included if they have symptomatic interstitial lung disease (ILD) - Grade 3-4 Women who are breast feeding or pregnant Sexually active women or men of childbearing potential who are not willing to use an effective contraceptive method during the study